Using NGS, single nucleotide variants in all genes involved in FH can be detected at the same time as indications of CNV in the LDLR gene can be received.

Dr Kristina Duvefelt, Section head for the Mutation Analysis Facility (MAF),

Dr Peter Benedek, Specialist M.D, Chief physician at Nyköping Hospital, Sweden.

1 Medium
1 Apricot

Devyser FH NGS

Reduce hands-on time from days to minutes with Devyser’s easy-to-use NGS library prep kit for complete characterization of genes involved in familial hypercholesterolemia.

  • Comprehensive gene panel for Familial hypercholesterolemia (FH)
  • Identify 12 SNPs in polygenic FH & the 6 SNPs to predict statin response
  • Single-tube workflow for fast results

Get in touch

Devyser FH NGS

Reduce hands-on time from days to minutes with Devyser’s easy-to-use NGS library prep kit for complete characterization of genes involved in familial hypercholesterolemia.

  • Comprehensive gene panel for Familial hypercholesterolemia (FH)
  • Identify 12 SNPs in polygenic FH & the 6 SNPs to predict statin response
  • Single-tube workflow for fast results

Designed for routine laboratory use

The Devyser FH kit is easy to implement and a highly cost-effective solution for NGS library preparation. With ready-to-use reagents and a user-friendly workflow, it suits both manual and automated processes.

Familial Hypercholesterolemia, also known as Autosomal Dominant Hypercholesterolemia (ADH), can be caused by mutations in the LDLR, APOB, PCSK9, APOE, STAP1 and LDLRAP1 genes, all of which can be detected with Devyser’s FH kit. Raised LDL-cholesterol concentrations can also have a polygenic cause that might explain the variable penetrance of the disease. Devyser’s FH kit enables the analysis of 12 polygenic SNPs influencing the LDL-cholesterol level.

Predict the effects of statin therapy

Statin drugs are highly effective in lowering blood concentrations of LDL-cholesterol, with concomitant reduction in risk of major cardiovascular events. Although statins are generally regarded as safe and well-tolerated, there is an interindividual difference in the response to statin treatment and some users may develop muscle symptoms, myopathy. Devyser FH enables the detection of several SNPs associated with treatment effect and adverse reactions to statin therapy.

Features and benefits

Data analysis

Workflow

No items found.

Customer testimonials

Download whitepaper

Related articles

Related products and accessories

Downloads

No items found.
Enter access code found in the lower right corner of the label on the kit box.
Finding files...
Oops! No files where found.
Download a specific Batch Release Certificate (BRC) below.
Finding files...
Oops! No files where found.

Product Details

RUO

Devyser FH
Complete sequencing of the following genes: LDLR, APOB, PCSK9, APOE, STAP1, LDLRAP1 Sequence determination of the following polygenic SNPs related to FH and/or statin treatment response: rs629301, rs1564348, rs1800562, rs2479409, rs3757354, rs4299376, rs6511720, rs8017377, rs11220462, rs1367117, rs429358, rs7412, rs646776, rs4149056, rs3798220, rs10455872
8-A109-24-RUO
Pack size: 
24
8-A109-48-RUO
Pack size: 
48